Revance Therapeutics said on
Thursday it has received the U.S. Food and Drug Administration’s
Financial Post Top Stories
Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.
By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300
approval for its injection to treat wrinkles that appear as
people become older.
(Reporting by Leroy Leo in Bengaluru)